Accucaps establishes SPC for high potency compounds
Accucaps said that the increase in growth of liquid filled soft gel formulated compounds is due to the increasing need to formulate high potency molecules that could not
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Immunovaccine’s DepoVax platform is a lipid depot-based vaccine delivery technology. The primary cell-derived biologic, IRX-2, designed to restore the immune system, seeks to overcome cancer-induced immune suppression and